Procalcitonin for the clinical laboratory: A review

Pathology

Volumn 39, Issue 4, 2007, Pages 383-390

  Schneider, Hans Gerhard ^a,b,c   Lam, Que Thanh ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Alfred Pathology Service   (Australia)

Author keywords

Calcitonin; Laboratory test; Procalcitonin; Prognosis; Sepsis

Indexed keywords

PROCALCITONIN;

BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CLINICAL LABORATORY; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; EUROPE; FEBRILE NEUTROPENIA; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE STRUCTURE; HORMONE SYNTHESIS; HUMAN; INTENSIVE CARE; PANCREATITIS; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEPTICEMIA; UNITED STATES;

EID: 34547702354     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701444564     Document Type: Article

References (78)

1. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512-25.
2. Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001; 131: 595-602.
3. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396-404.
4. Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-84.
5. Mitaka C. Clinical laboratory differentiation of infectious versus noninfectious systemic inflammatory response syndrome. Clin Chim Acta 2005; 351: 17-29.
6. Whang KT, Steinwald PM, White JC, et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998; 83: 3296-301.
7. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-8.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
9. Delevaux I, Andre M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62: 337-40.
10. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28: 950-7.
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-7.
12. Christ-Crain M, Muller B. Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 2005; 135: 451-60.
13. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001-6.
14. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, Fernandez Pou J. Spanish Society of Pediatric Emergencies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003; 22: 895-903.
15. Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 2002; 48: 263-70.
16. Barassi A, Pallotti F, Melzi d'Eril G. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004; 50: 1878.
17. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
18. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
19. Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 1: 331-3.
20. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
21. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999; 27: 2172-6.
22. Brunkhorst FM, Wegscheider K, Forychi ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26: S148-52.
23. Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, Thomas R. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 2000; 26: 1232-8.
24. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-83.
25. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28: 2793-8.
26. Harbarth S, Holeckova K, Froidevaux C, et al. and the Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
27. Liaudat S, Dayer E, Praz G, Bille J, Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20: 524-7.
28. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002; 28: 1351-6.
29. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002; 46: 398-404.
30. Tugrul S, Esen F, Celebi S, et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002; 30: 747-54.
31. Bell K, Wattie M, Byth K, et al. Procalcitonin: A marker of bacteraemia in SIRS. Anaesth Intensive Care 2003; 31: 629-36.
32. Balci C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoǧlu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7: 85-90.
33. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-41.
34. Du B, Pan J, Chen D, Li Y. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl) 2003; 116: 538-42.
35. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004; 8: R234-42.
36. Clec'h C, Ferriere F, Karoubi P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-9.
37. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004; 10: 628-33.
38. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005; 33: 257-63.
39. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
40. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
41. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417-21.
42. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112: 1054-60.
43. Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, Hart CA. Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 2002; 86: 282-5.
44. Matesanz JL, Fernandez E, Fernandez JM, Viejo G. Plasma procalcitonin and C-reactive protein concentrations in pediatric patients with Epstein-Barr virus infection. Clin Chem 2003; 49: 2103-4.
45. Sachse C, Dressler F, Henkel E. Increased serum procalcitonin in newborn infants without infection. Clin Chem 1998; 44: 1343-4.
46. Martin-Denavit T, Monneret G, Labaune JM, et al. Usefulness of procalcitonin in neonates at risk for infection. Clin Chem 1999; 45: 440-1.
47. Chiesa C, Pellegrini G, Panero A, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60-8.
48. Elsammak M, Hanna H, Ghazal A, Edeen FB, Kandil M. Diagnostic value of serum procalcitonin and C-reactive protein in Egyptian children with streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2006; 25: 174-6.
49. Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84: 332-6.
50. Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17: 623-7.
51. Gurgoze MK, Akarsu S, Yilmaz E, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005; 20: 1445-8.
52. Pecile P, Miorin E, Romanello C, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004; 114: e249-54.
53. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998; 102: 1422-5.
54. Leclerc F, Leteurtre S, Noizet O, et al. Procalcitonin as a prognostic marker in children with meningococcal septic shock. Arch Dis Child 2002; 87: 450.
55. Marc E, Menager C, Moulin F, et al. Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak. (French.) Arch Pediatr 2002; 9: 358-64.
56. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 1718-25.
57. Pihusch M, Pihusch R, Fraunberger P, et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76: 93-101.
58. Hambach L, Eder M, Dammann E, et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643-51.
59. Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000; 7: 889-92.
60. Ortega M, Rovira M, Filella X, et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 2004; 126: 372-6.
61. Lam QT, Au P, Schwarer A, Schneider HG. Measurement of procalcitonin in the investigation of fever in the bone marrow transplant population. Clin Biochem Rev 2002; 23: Abstr 77.
62. Shafiq N, Malhotra S, Bhasin DK, Rana S, Siddhu S, Pandhi P. Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach. J Pancreas 2005; 6: 231-7.
63. Modrau IS, Floyd AK, Thorlacius-Ussing O. The clinical value of procalcitonin in early assessment of acute pancreatitis. Am J Gastroenterol 2005; 100: 1593-7.
64. Melzi D'Eril GV, Merlini G, Finazzi S, Bosoni T, Barakat B, Pezzilli R. Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complications. Clin Chem 2000; 46: 428-30.
65. Brunkhorst FM, Eberhard OK, Brunkhorst R. Early identification of biliary pancreatitis with procalcitonin. Am J Gastroenterol 1998; 93: 1191-2.
66. Müller CA, Uhl W, Printzen G, et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46: 233-8.
67. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-40.
68. Bihari D. Monitoring procalcitonin is of value in acute pancreatitis. BMJ 2004; 329: 232.
69. Herget-Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001; 16: 975-9.
70. Level C, Chauveau P, Delmas Y, et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001; 16: 980-6.
71. Madhi SA, Heera JR, Kuwanda L, Klugman KP. Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med 2005; 2: e38.
72. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004; 109: 1707-10.
73. Polzin A, Pletz M, Erbes R, et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003; 21: 939-43.
74. Hollenstein U, Looareesuwan S, Aichelburg A, et al. Serum procalcitonin levels in severe Plasmodium falciparum malaria. Am J Trop Med Hyg 1998; 59: 860-3.
75. Wagner FD, Jonitz B, Potapov EV, et al. Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation 2001; 104(Suppl 1): I192-6.
76. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174: 84-93.
77. el Moussaoui R, de Borgie CA, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006; 332: 1355.
78. Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkotter U. Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg 2006; 391: 87-94.